VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 2.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $434,182 | -74.2% | 100,505 | -60.7% | 0.01% | -66.7% |
| Q2 2023 | $1,684,160 | +1181.6% | 255,563 | +1220.5% | 0.03% | +1250.0% |
| Q1 2023 | $131,414 | +162139.5% | 19,354 | +75.9% | 0.00% | +100.0% |
| Q4 2022 | $81 | -99.9% | 11,004 | -1.8% | 0.00% | -50.0% |
| Q2 2022 | $122,000 | +4.3% | 11,206 | +8.8% | 0.00% | 0.0% |
| Q1 2022 | $117,000 | -18.2% | 10,304 | -5.6% | 0.00% | 0.0% |
| Q4 2020 | $143,000 | – | 10,910 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |